Initial experience with regadenoson as a pharmacologic stress agent for myocardial perfusion imaging post FDA approval

被引：0
|
作者：
Majmundar, H. [1 ]
Coats, N. P. [1 ]
Vernotico, S. [1 ]
Doan, J. H. [1 ]
Hernandez, T. M. [1 ]
Evini, M. [1 ]
Hepner, A. D. [1 ]
Ip, T. K. [1 ]
Miyamoto, M. I. [1 ]
Thomas, G. S. [1 ]
机构：
[1] Mission Internal Med Grp, Mission Viejo, CA USA
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2011年 / 13卷 / 0A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
286
引用
收藏
页码：A59 / A60
页数：2
相关论文
共 50 条
  • [1] Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands
    Jager, P. L.
    Buiting, M.
    Mouden, M.
    Oostdijk, A. H. J.
    Timmer, J.
    Knollema, S.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2014, 33 (06): : 346 - 351
  • [2] Regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in patients with bronchoconstrictive disease
    Salgado-Garcia, C.
    Jimenez-Heffernan, A.
    Sanchez de Mora, E.
    Lopez-Martin, J.
    Ramos-Font, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S245 - S245
  • [3] Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis
    Palani, Gurunanthan
    Husain, Zehra
    Salinas, Rafael Cabrera
    Karthikeyan, Vanji
    Karthikeyan, Aarthee S.
    Ananthasubramaniam, Karthik
    JOURNAL OF NUCLEAR CARDIOLOGY, 2011, 18 (04) : 605 - 611
  • [4] Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis
    Gurunanthan Palani
    Zehra Husain
    Rafael Cabrera Salinas
    Vanji Karthikeyan
    Aarthee S. Karthikeyan
    Karthik Ananthasubramaniam
    Journal of Nuclear Cardiology, 2011, 18 : 605 - 611
  • [5] Regadenoson stress for myocardial perfusion imaging
    Reyes, Eliana
    FUTURE CARDIOLOGY, 2016, 12 (01) : 59 - 67
  • [6] Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging
    Hendel, RC
    Bateman, TM
    Cerqueira, MD
    Iskandrian, AE
    Leppo, JA
    Blackburn, B
    Mahmarian, JJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (11) : 2069 - 2075
  • [7] Pharmacologic stress myocardial perfusion Imaging
    Patel, Rakesh N.
    Arteaga, Roque B.
    Mandawat, Mahendra. K.
    Thornton, John W.
    Robinson, Vincent J. B.
    SOUTHERN MEDICAL JOURNAL, 2007, 100 (10) : 1006 - 1014
  • [8] Pharmacologic stress myocardial perfusion imaging
    Li, Yunchun
    Guan, Changtian
    Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering, 2000, 17 (04): : 457 - 460
  • [9] SAFETY OF REGADENOSON AS A PHARMACOLOGIC STRESS AGENT FOR MYOCARDIAL PERFUSION IMAGING IN STAGE 3, 4 AND 5 CHRONIC KIDNEY DISEASE PATIENTS NOT ON HEMODIALYSIS
    Ananthasubramaniam, Karthikeyan
    Palani, Gurunanthan
    Husain, Zehra
    Karthikeyan, Aarthee
    Karthikeyan, Vanji
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [10] Regadenoson, a Novel Pharmacologic Stress Agent for Use in Myocardial Perfusion Imaging, Does Not Have a Direct Effect on the QT Interval in Conscious Dogs
    Zhao, Gong
    Serpllion, Sabrina
    Shryock, John
    Messina, Eric
    Xu, Xiaobin
    Ochoa, Manuel
    Belardinelli, Luiz
    Hintze, Thomas H.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 52 (05) : 467 - 473
12345